• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza and respiratory syncytial virus screening for the detection of asymptomatically infected patients in hematology and oncology

tetano

Editor, Senior Moderator
GMS Hyg Infect Control. 2018 Sep 24;13:Doc08. doi: 10.3205/dgkh000314. eCollection 2018.
[h=1]Influenza and respiratory syncytial virus screening for the detection of asymptomatically infected patients in hematology and oncology.[/h] Baier C[SUP]1[/SUP], Linderkamp C[SUP]2[/SUP], Beilken A[SUP]2[/SUP], Thol F[SUP]3[/SUP], Heuser M[SUP]3[/SUP], Ebadi E[SUP]1[/SUP], Ganzenmueller T[SUP]4[/SUP], Heim A[SUP]4[/SUP], Bange FC[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] in English, German
Introduction: Respiratory syncytial virus (RSV) and influenza virus infections are a significant healthcare risk for immunocompromised patients. In addition to community onset, nosocomial acquisition and transmission may also occur. Detection of asymptomatic shedders (e.g., patients in the incubation period or immunosuppressed long term shedders) facilitates control of nosocomial transmission. Methods: To strengthen the existing infection control concept, a PCR-based screening for RSV and influenza virus was implemented for all patients lacking respiratory symptoms (asymptomatic patients) who were hospitalized on an adult and a pediatric hemato-oncological ward. Laboratory results of this screening were analyzed retrospectively. Results: 665 respiratory specimens were obtained for screening from 251 patients (26% were 18 years and younger) from December 2016 to April 2017. In 23 patients without respiratory symptoms, either influenza virus or RSV infection was found, resulting in a detection rate of about 9%. In 6 patients, the infection was presumably detected during the incubation period, because an increase of viral load was observed in subsequent specimens. Positive screening results facilitated timely implementation of adequate infection control precautions. Nosocomial clusters of RSV or influenza were not detected during the screening period on the two wards. Conclusion: The seasonal screening program expanded our existing infection control concept in terms of patients lacking respiratory symptoms who shed influenza virus or RSV. It enabled us to identify 23 RSV or influenza infections in patients lacking respiratory symptoms in a 4-month period and thus to rapidly take isolation precautions.


[h=4]KEYWORDS:[/h] PCR; cross infection; infection control; influenza; oncology; respiratory syncytial virus; screening

PMID: 30460173 PMCID: PMC6234716 DOI: 10.3205/dgkh000314
Free full text
 
Back
Top Bottom